Iodoxamic acid

Iodoxamic acid

Clinical data
Trade names	Endobil
Other names	3-[3-[2-[2-[2-[3-[(3-Carboxy-2,4,6-triiodophenyl)amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid
ATC code	V08AC01 (WHO)
Identifiers
IUPAC name 3-{1-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]-3,6,9,12-tetraoxapentadecan-15-amido}-2,4,6-triiodobenzoic acid
CAS Number	31127-82-9
PubChem CID	35740
DrugBank	DB13539
ChemSpider	32877
UNII	NS1Y283HW4
KEGG	D01312
ChEMBL	ChEMBL1201324
CompTox Dashboard (EPA)	DTXSID4057710
ECHA InfoCard	100.045.875
Chemical and physical data
Formula	C26H26I6N2O10
Molar mass	1287.925 g·mol^−1
3D model (JSmol)	Interactive image
SMILES OC(=O)c(c1I)c(I)cc(I)c1NC(=O)CCOCCOCCOCCOCCC(=O)Nc(c2I)c(I)cc(I)c2C(=O)O

Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent.^[1] It features both a high iodine content as well as several hydrophilic groups.

See also

• Iodinated contrast

References

1. Mützel W, Taenzer V, Wolf R (1976). "Biotransformation of ioglycamic acid, iodoxamic acid and iotroxic acid in man". Investigative Radiology. 11 (6): 598–601. doi:10.1097/00004424-197611000-00018. PMID 1036733.